The award, endowed with €2,500, recognizes outstanding scientific contributions in the field of hematopoietic stem cell transplantation immunology, with a particular focus on the biology of graft-versus-host disease (GvHD) and graft-versus-leukemia (GvL) reactions. The award is supported by an educational grant from Neovii Biotech GmbH (Gräfelfing, Germany).
Early-career researchers are cordially invited to submit their most recent scientific work for consideration. Eligible candidates must be 40 years of age or younger and should have authored a paper that was published or accepted for publication in 2024 or 2025.
The selection will be carried out by the Scientific Committee of the GvH/GvL Symposium under the supervision of Prof. Dr. Hans-Jochem Kolb.
The award will be formally presented during the GvH/GvL Symposium in Regensburg, held March 11–13, 2026.
Application materials should include:
The relevant scientific publication
A curriculum vitae (CV)
Applications must be submitted by January 31, 2026, via email to:
Prof. Dr. Ernst Holler
📧 ernst.holler@klinik.uni-regensburg.de
We look forward to receiving your applications.
Within the Collaborative Research Centre/Transregio (CRC/TRR) 221 innovative immune modulation strategies will be investigated to separate GvHD from GvL effects in order to enhance the safety and efficacy of allo-HSCT in the future.
